Plasmonix

Evergreen Advisors served as the Financial Advisor to Plasmonix, Inc., a life science products company, for their Series A equity financing led by Maryland Healthcare Product Development Corporation. Plasmonix was spun out of the University of Maryland Baltimore County to commercialize Metal Enhanced Fluorescence (MEF) discoveries made at the University’s Institute of Fluorescence. Additional services provided by Evergreen include financial modeling, financial statement preparation and analysis, and full suite of electronic account management services.